HIV-positive TB patients on ART (antiretroviral therapy) in Upper-middle income (World Bank)
Upper-middle income (World Bank): HIV-positive TB patients on ART (antiretroviral therapy) was 86.0% in 2024. ▲ Rising
Latest (2024)
86.0%
Change on year
up 6.2%
Rank
6th
of 11 groups
All-time high
92.0%
in 2003
All-time low
29.0%
in 2007
Years of data
22
2003–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Upper-middle income (World Bank), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hiv-positive tb patients on art (antiretroviral therapy) in Upper-middle income (World Bank) stood at 86.0%.
Compared with earlier readings it is up 6.2% on the previous year and up 13.2% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Upper-middle income (World Bank) peaked at 92.0% in 2003 and was at its lowest, 29.0%, in 2007.
The long-run direction has been consistently rising across the 22 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 92.0% | — |
| 2004 | 55.0% | -40.2% |
| 2005 | 43.0% | -21.8% |
| 2006 | 56.0% | +30.2% |
| 2007 | 29.0% | -48.2% |
| 2008 | 32.0% | +10.3% |
| 2009 | 45.0% | +40.6% |
| 2010 | 54.0% | +20.0% |
| 2011 | 48.0% | -11.1% |
| 2012 | 54.0% | +12.5% |
| 2013 | 70.0% | +29.6% |
| 2014 | 76.0% | +8.6% |
| 2015 | 77.0% | +1.3% |
| 2016 | 82.0% | +6.5% |
| 2017 | 84.0% | +2.4% |
| 2018 | 81.0% | -3.6% |
| 2019 | 78.0% | -3.7% |
| 2020 | 82.0% | +5.1% |
| 2021 | 79.0% | -3.7% |
| 2022 | 78.0% | -1.3% |
| 2023 | 81.0% | +3.8% |
| 2024 | 86.0% | +6.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 50.3% | 29.0% | 92.0% | 7 |
| 2010s | 70.4% | 48.0% | 84.0% | 10 |
| 2020s | 81.2% | 78.0% | 86.0% | 5 |
More health data for Upper-middle income (World Bank)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 212 (2025)
- Number of under-five deaths, annual growth rate -6.19 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -4.24 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.78 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Upper-middle income (World Bank)?
- Hiv-positive tb patients on art (antiretroviral therapy) in Upper-middle income (World Bank) was 86.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Upper-middle income (World Bank)?
- The highest recorded value was 92.0% in 2003.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 29.0% in 2007.
- How does Upper-middle income (World Bank) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Upper-middle income (World Bank) ranks 6th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is up 13.2%. The long-run trend across the full record is rising.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).